Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Genfit S.A.

Start price
Target price
Perf. (%)
€25.16
10.02.16
€75.00
11.08.16
-3.12%
11.08.16

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€43.45
10.02.16
€47.81
01.03.16
10.19%
01.03.16

buy
Inovio Pharma

Start price
Target price
Perf. (%)
€5.30
10.02.16
€8.84
23.02.16
11.79%
23.02.16

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€9.42
10.02.16
€11.00
12.02.16
0.12%
12.02.16

buy
Novartis AG

Start price
Target price
Perf. (%)
€65.49
10.02.16
€74.00
30.06.16
17.39%
30.06.16

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€43.79
10.02.16
€47.81
01.03.16
9.33%
01.03.16

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€77.83
09.02.16
€159.09
09.08.16
-69.33%
09.08.16

buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€50.31
09.02.16
€61.94
23.02.16
9.07%
23.02.16

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.88
08.02.16
€5.00
11.05.16
119.23%
11.05.16

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.79
08.02.16
€100.00
28.04.16
14.98%
28.04.16

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€43.99
06.02.16
€100.00
08.08.16
39.26%
08.08.16

buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€6.70
06.02.16
€9.02
08.08.16
-58.14%
08.08.16

buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€43.70
05.02.16
€56.00
08.08.16
6.08%
08.08.16

buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€22.01
05.02.16
€45.00
05.08.16
-7.31%
05.08.16

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€244.61
04.02.16
€387.86
08.02.16
-6.48%
08.02.16

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.35
03.02.16
€90.00
09.02.17
-18.07%
09.02.17

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€76.75
02.02.16
€117.26
31.10.16
-11.45%
31.10.16

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€49.66
02.02.16
€55.02
02.08.16
5.42%
02.08.16

buy
Celgene Corp.

Start price
Target price
Perf. (%)
€89.93
01.02.16
€117.26
10.01.17
20.57%
10.01.17

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€46.54
30.01.16
€53.00
16.09.16
21.25%
16.09.16

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€74.59
29.01.16
€91.55
23.01.17
-11.89%
23.01.17

buy
BB Biotech AG

Start price
Target price
Perf. (%)
€43.50
29.01.16
€60.00
08.02.16
-10.34%
08.02.16

buy
Medigene AG

Start price
Target price
Perf. (%)
€7.21
28.01.16
€8.85
07.03.16
7.48%
07.03.16

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€21.06
28.01.16
€23.42
04.11.21
90.58%
17.07.21

buy
CytoTools AG

Start price
Target price
Perf. (%)
€16.05
27.01.16
€17.00
27.07.16
-32.93%
27.07.16